Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioRestorative Therapies, Inc. - Common Stock (NQ:BRTX)

1.484 -0.026 (-1.75%)
Streaming Delayed Price Updated: 2:44 PM EDT, Sep 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 36,343
Open 1.510
Bid (Size) 1.480 (17)
Ask (Size) 1.490 (1)
Prev. Close 1.510
Today's Range 1.480 - 1.515
52wk Range 1.210 - 2.550
Shares Outstanding 7,978,117
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Earnings Scheduled For August 12, 2025
 
Via Benzinga
Earnings Outlook For BioRestorative Therapies
 
Via Benzinga

Performance

YTD
-0.4%
-0.4%
1 Month
-3.7%
-3.7%
3 Month
-8.4%
-8.4%
6 Month
-11.2%
-11.2%
1 Year
-17.6%
-17.6%

More News

Read More
From Phase 2 Trial Results To Expansion Mode: A Look At BioRestorative's Novel Approach To Treating Chronic Pain
Via NewMediaWire
From Phase 2 Trial Results To Expansion Mode: A Look At BioRestorative's Novel Approach To Treating Chronic Pain
Via TheNewswire.com
BioRestorative Announces Share Repurchase Program
Via PressReach
BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease
Via PressReach
Earnings Preview For BioRestorative Therapies
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
BioRestorative Welcomes Serial Regenerative Medicine Entrepreneur, Company Builder and Leader, Sandy Lipkins, to BRTX Team
Via PressReach
BioRestorative to Present Major Update on Promising Preliminary Phase 2 BRTX-100 Data at ISSCR 2025
Via PressReach
Uncovering Potential: BioRestorative Therapies's Earnings Preview
Via Benzinga
Leveraging Stem Cells To Fight Chronic Lower Back Pain And Obesity With BioRestorative Therapies
Via NewMediaWire
Earnings Scheduled For May 14, 2025
Via Benzinga
Leveraging Stem Cells To Fight Chronic Lower Back Pain And Obesity With BioRestorative Therapies
Via TheNewswire.com
BioRestorative Therapies Receives FDA Fast Track Approval For BRTX-100 To Treat Chronic Lumbar Disc Disease
Via NewMediaWire
BioRestorative Therapies Receives FDA Fast Track Approval For BRTX-100 To Treat Chronic Lumbar Disc Disease
Via TheNewswire.com
Which stocks have an unusual volume on Thursday?
Via Chartmill
Earnings Scheduled For March 27, 2025
Via Benzinga
On Tuesday, there are stocks with unusual volume. Let's take a look.
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
BioRestorative Ends Q3 In ‘Strong’ Financial Position, Reports Positive Data For Its Phase 2 BRTX-100 Chronic Back Pain Trial
Via News Direct
Topics Intellectual Property
Presenting Encouraging Data, Acquiring Licenses, Issuing Patents And More – BioRestorative's Inroads Bringing Its Stem Cell Therapies To Market
Via News Direct
Topics Intellectual Property
BioRestorative Therapies Lower Back Candidate Shows Decrease In Pain, Increased Function
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Armed With Its Patent Portfolio, BioRestorative Therapies Has Success In The Laboratory And At The Negotiating Table: Is Profitability Close Behind?
Via News Direct
Topics Intellectual Property

Frequently Asked Questions

Is BioRestorative Therapies, Inc. - Common Stock publicly traded?
Yes, BioRestorative Therapies, Inc. - Common Stock is publicly traded.
What exchange does BioRestorative Therapies, Inc. - Common Stock trade on?
BioRestorative Therapies, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for BioRestorative Therapies, Inc. - Common Stock?
The ticker symbol for BioRestorative Therapies, Inc. - Common Stock is BRTX on the Nasdaq Stock Market
What is the current price of BioRestorative Therapies, Inc. - Common Stock?
The current price of BioRestorative Therapies, Inc. - Common Stock is 1.484
When was BioRestorative Therapies, Inc. - Common Stock last traded?
The last trade of BioRestorative Therapies, Inc. - Common Stock was at 09/16/25 02:44 PM ET
What is the market capitalization of BioRestorative Therapies, Inc. - Common Stock?
The market capitalization of BioRestorative Therapies, Inc. - Common Stock is 11.84M
How many shares of BioRestorative Therapies, Inc. - Common Stock are outstanding?
BioRestorative Therapies, Inc. - Common Stock has 12M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.